Clinical Trials Logo

Clinical Trial Summary

Introduction: Cerebral small vessel disease (SVD) is associated with age-related disabilities including dementia, depression, physical and functional impairment. Chinese are more prone to developing SVD than Caucasians. Physical exercise may improve multiple negative consequences associated with SVD.

Objective and hypothesis to be tested: To examine the effects of a 24-week structured aerobic dance training on cognition, mood, physical and daily functions in stroke and dementia free older adults with SVD, and whether such effects are mediated through improved cerebral vasomotor reactivity (CVR), a marker of cerebral autoregulation which is impaired in SVD.

Design and subjects: Rater-blind RCT comparing the effects of 24-week of structured aerobic dance training upon cognition, mood, physical and daily functions on 110 community dwelling, stroke- and dementia-free persons aged ≥65 with MRI evidence of significant SVD, defined as the presence of multiple (≥2) lacunes and/or early confluent or confluent WML.

Interventions: Participants are randomized in a 1:1 ratio into a 24-week of structured therapist-led group aerobic dance training with home practice or simple stretching plus health education control group.

Main outcome measures: Cognition, mood, physical and daily functions and CVR measured using Transcranial Doppler at baseline, weeks 12, 24 and 36.

Data analysis: Intent-to-treat with multiple imputations with treatment efficacy analyzed using mixed effects models. Mediation effects of CVR between aerobic dance training and treatment outcomes tested using mediation models.

Expected results: In persons with significant SVD, aerobic dance training improves cognitive, mood, physical and daily functions and such effects are mediated by changes in CVR.


Clinical Trial Description

Cerebral small vessel disease (SVD) is manifested as age-related white matter lesions (WML) and lacunar infarcts and on brain imaging. SVD is prevalent in the elderly population. In community dwelling persons ≥ 60 years of age, up to a quarter had lacunar infarcts and 96% had varying degree of WML. Significant SVD, namely early confluent or confluent WML and multiple lacunar infarcts, are found in up to 1 in every 5 elderly persons. In a previous study we found that Chinese are more prone to develop significant SVD than Caucasians. SVD is associated with a plethora of age-related disabilities such as dementia, falls, depression, impaired daily functioning and death Cognition - SVD is the most common cause of vascular cognitive impairment (VCI) and vascular dementia, which is the second most prevalent type of dementia. Community elderly persons with SVD had two-fold increased risk of developing dementia when compared to those without. SVD may direct damage neural structures, disrupt connectivity or cause atrophy in brain regions important for cognitive functioning. Depression - Disconnection of frontosubcortical pathways by SVD contributes to late-life depression, and increased comorbidity of depression and SVD has been observed in the older populations. Depression contributes to poor quality of life and death in older persons.

Physical impairment - increased severity of SVD is associated with poor physical functions including poor gait and balance. SVD is a strong risk factor for falls, a major contributing factor for disability and death in older persons. In summary, non-disabled older adults with SVD are at high risk of multiple disabilities.

As the elderly population in Hong Kong is projected to triple over the next 30 years, means to prevent age-related disabilities such as cognitive decline, depression and physical impairments in vulnerable individuals are of enormous importance to the patient, family and healthcare system. Existing preventive therapies mainly involve medications to control vascular risk factors associated with SVD. Primary prevention by means of lifestyle intervention is therefore of utmost importance.

Evidence on effects of physical activities upon cognition, mood and physical functions The health values of physical activities are well recognized. Physical activities can be performed by anybody at any time and place at minimal cost. Physical activities are shown to improve the clinical conditions associated with SVD. For cognition, physical activities are associated with reduced risk of cognitive decline in normal and cognitively impaired elderly persons. Aerobic and strength training improved executive functions, memory and general cognitive functions in community-dwelling adults with mild cognitive impairment. The investigators showed that in a large cohort (n=1,013) of stroke patients free of dementia before the stroke, participation in regular physical activities reduced 79% of risk of incident dementia after stroke. With regard to the mechanism, physical activities may improve endothelial functions and blood perfusion and neuroplasticity in brain regions mediating cognitive functions. Moreover, physical exercise may protect cognition by reducing incident strokes, which is particular relevant to people with SVD due to their increased risk of strokes. A randomized controlled trial (RCT) showed that a 24-week, 3 x 50-minute per week of moderate intensity exercise intervention significantly improved cognitive functions in patients at risk of AD, with outcome effect size superior to that reported for drug treatment in another study. Moreover, treatment benefits persisted at least one year after active intervention, suggesting that physical exercise is associated with enduring changes in the neurological substrate underpinning cognitive functioning. However, this study only recruited patients likely to have degenerative (Alzheimer's) pathology. For mood, physical activities may protect against depression in older adults. For physical functions, the investigators previously showed that physical exercise training improved balance, gait performance, exercise endurance and quality of life in local patients with Parkinson's Disease (PD). Taken together, there is good evidence that physical activities can improve many of the negative consequences of cerebral SVD.

Possible biological mechanism underlying physical exercise in SVD The development of SVD is hypothesized to be related to endothelial dysfunction that results from chronic hypertension impairs cerebral vasomotor reactivity (CVR), a marker of cerebral autoregulation. Changes in CVR may reflect impairment in the homeostasis of blood pressure in the brain, hence cerebral perfusion becomes more dependent on the systemic blood pressure. Ischemia occurs in response to drop of systemic blood pressure and lead to hypoperfusion and subsequently the development of SVD. Using Transcranial Doppler (TCD) ultrasonography, our group previously showed that decreased CVR is associated with SVD. Reduced CVR is linked to cognitive decline, depression and poor physical functions in elderly persons. Physical exercise may lead to significant improvement in CVR. These data suggest that physical exercise is likely to benefit cognition, mood and physical functions in persons with SVD due to its positive effects on CVR.

Dancing as a mean of physical activity intervention Dance is a rhythmic movement usually performed with music. To many, it is a pleasurable activity that can be taken up as a hobby and social activity and therefore engagement can be self-sustaining. It is of minimal-cost and can be performed even in older persons with physical and cognitive impairment. Dancing involves movement of the body and limbs and is in itself a physical training. It also involves memory, attention, sensory stimulation, social interaction, emotional perception and expression that presumably could protect against cognitive decline and depression. Dance training may improve verbal fluency, word list delayed recall and word list recognition in older adults with metabolic syndrome, suggesting that dance may be effective in preventing cognitive decline. Aerobic dance also has been shown to enhance exercise endurance strength, balance, agility and gait performance in older adults. Our team had previously designed and implemented a balance dance to a group of patients with PD for 8 weeks. Together with other training, balance ability and walking speed increased and the effects lasted for 12 months after treatment completion. Given the likely positive effects of aerobic dance, it appears to be a good exercise candidate for enhancing cognitive, mood and physical functions in patients with cerebral SVD.

Data Collection Assessment of cognitive functions The 30-minute protocol of the National Institute of Neurological Diseases and Stroke - Canadian Stroke Network VCI protocols will be used. The 30-minute protocol provides a comprehensive assessment of cognitive functions with emphasis on executive functions, psychomotor speed and memory, which are the cognitive domains predominately impaired in VCI. With support from Health and Health Service Research fund (PI: Vincent CT MOK; Reference Number 06070231), the investigators adapted and validated the 30-minute protocol in a group of Chinese stroke patients and controls and demonstrated good external validity (area under ROC=0.79 [95%CI 0.69-0.89], p<0.001) in differentiating stroke patients from non-stroke controls and concurrent validity with functional measures. In addition to the 30-minute protocol, the digit span tests from the Wechsler Memory Scale will be administered because of the involvement of immediate attention and working memory in VCI.

Measure of depressive symptoms The 15-item Geriatric Depression Scale (GDS), which is a self-reported questionnaire to rate depressive symptoms in elderly persons, will be used. It has been used in local study on SVD patients and demonstrated excellent classification power >90% in detecting depression in the local elderly population.

Measures of physical functions The Mini-Balance Evaluation Systems Test (Mini-BESTest) will be used to assess dynamic balance performance of individuals. The 14-item Mini-BESTest represents 4 dynamic balance domains: anticipatory postural adjustments, postural responses, sensory orientation and stability in gait. Each item is rated from 0 to 2, and the total score ranges from 0-28 with a higher score indicating better balance.

The Timed-up-and-go test (TUG) will be used to examine functional mobility of subjects. This test measures the time which participants takes to rise from the chair, walk 3 meters, turn around, walk back to the chair and sit down.

The 6-minute walk test will be used to determine the walking capacity. This test measures the distance (in metres) participants walk in 6 minutes. Participants will walk at their own speed, and stops and resting are allowed if necessary.

Measure of daily functions The Lawton's Instrumental Activities of Daily Living (IADL) will be used to assess complex activities of daily functions that are impaired early in patients with SVD. It take about 10 minutes to administer and contains 8 items including ability to use telephone, shopping, food preparation, housekeeping, laundry, taking transportation, handling medications and finances. It is has been used as a primary outcome instrument in the Pan-European Leukoaraiosis and Disability in the Elderly Study in SVD.

Measure of overall physical activities Physical activities performed outside of training session will be recorded using the long form of the International Physical Activity Questionnaire (IPAQ). The IPAQ has been very widely used in studies of physical activity across different ages and medical conditions (http://www.ipaq.ki.se/publications.htm). The IPAQ records the types, frequency and duration of physical activities across 4 activity domains including leisure time physical activity, domestic related physical activities, work-related and transportation related physical activities. The IPAQ yields scores for walking, moderate-intensity and vigorous-intensity activities with each of these activity domains. A total score is calculated by summing the duration and frequency for all types of activities across all domains. This score will be used to account for the potential confounding effects of physical activities performed outside of training session in both groups.

It is estimated that it takes approximately 2 hours to complete the assessment and TCD examination. To avoid rater bias, the research assistant (RA) who performs the study assessment will be blind to treatment allocation and encouraged not to discuss with the participants about the interventions. Clinical assessments will be performed by a trained RA under the supervision of a qualified clinical psychologist (PI of this application).

TCD Examination TCD examination will be performed at baseline, weeks 12, 24 and 36. A 2-MHz pulsed Doppler hand-held probe is used to insonate the middle cerebral artery (MCA) through temporal window above the zygomatic arch at a depth of 52-56mm, and the vertebral artery (VA) through occipital window at a depth of 64mm. The Pulsatility Index (PI) and Breath Holding Index (BHI) will be calculated. The PI is a measure of vascular resistance of cerebral vessels. The mean PI of the middle MCA and vertebral VA will be obtained. A previous study by the investigators showed that these measures highly differentiated stroke patients with and without WML on MRI (AUC = 0.85 [MCA] and 0.81 [VA], sensitivity and specificity between 70 and 82%]). According to the standard protocol, the simple breath holding procedure will be performed during the same TCD session to obtain the BHI, which will serve as a marker of CVR. A trained postgraduate research student under the supervision of a broad certified neurologist (Co-A Vincent MOK) will perform the TCD blind to participant's treatment allocation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02730065
Study type Interventional
Source Chinese University of Hong Kong
Contact Adrian Wong, PhD
Phone 852-25587122
Email adrianwong@cuhk.edu.hk
Status Recruiting
Phase N/A
Start date May 2016
Completion date February 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02248311 - "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population N/A
Completed NCT01604486 - Natural Ischaemic Preconditioning Before First Myocardial Infarction N/A
Active, not recruiting NCT00627029 - Evaluation of Programs of Coordinated Care and Disease Management N/A
Recruiting NCT04336852 - Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function N/A
Not yet recruiting NCT06429332 - International Care Bundle Evaluation in Cerebral Hemorrhage Research Phase 4
Not yet recruiting NCT05925699 - National Database of the Virtual Institute of Cerebrovascular Diseases
Recruiting NCT04443439 - Assess the Risk of Cerebrovascular Disease
Recruiting NCT04525144 - EGb 761 in the Syndrome of MCI With Concomitant CVD Phase 2
Completed NCT02553655 - Remote Ischemic Limb Preconditioning In Healthy Volunteers N/A
Recruiting NCT00385385 - RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease Phase 2
Recruiting NCT05247931 - Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
Completed NCT02665585 - Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS) N/A
Recruiting NCT05834673 - VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) Phase 4
Recruiting NCT06115213 - The North Kynouria Project N/A
Terminated NCT02440646 - Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
Completed NCT01924312 - Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease N/A
Completed NCT00333164 - Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis Phase 3
Not yet recruiting NCT06241482 - Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care N/A
Enrolling by invitation NCT02694094 - Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Not yet recruiting NCT04696120 - Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Phase 2